The Goldman Sachs Group, Inc.

🇺🇸New York Stock Exchange
Back to all articles
The Goldman Sachs Group, Inc. stock analysis GS overview
Slightly Bullish +25

Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more - CNBC

🏦 Goldman Sachs shares fell over 2% despite beating earnings estimates for Q1, with EPS of $17.55 on $17.23 billion revenue.

💰 However, FICC trading was significantly underperforming consensus at $4.01 billion versus a $4.92 billion expectation.

📈 Revolution Medicines stock surged 37% after its pancreatic cancer drug daraxonrasib showed patients lived 13.2 months versus 6.7 months on chemo in Phase 3 trial data.

🛍️ Williams-Sonoma gained over 2% following a buy rating upgrade from Goldman Sachs, citing attractive valuation and strong brand portfolio.

📉 Best Buy shares dropped 4% after Goldman Sachs downgraded the retailer to sell due to anticipated risk to sales post-Q1 from higher memory costs in laptops.

🏠 Toll Brothers and Pultegroup both rose over 1% after Evercore ISI upgraded them to outperform, noting bad news may be priced in.

⚡ Fastenal's industrial shares slid more than 4% even though Q1 earnings of $0.30 per share and $2.2 billion revenue met Wall Street expectations.

🛢️ Energy stocks advanced as oil prices climbed above $103 following a U.S. Navy blockade announcement on the Strait of Hormuz, lifting Targa Resources, APA Corporation, Phillips 66, Chevron, and Exxon Mobil.

⛴️ Cruise line stocks declined due to fears over demand and rising input costs, with Carnival down 4%, Norwegian off 3%, and Royal Caribbean slipping over 2%.

✈️ Airlines fell broadly amid similar demand concerns and high jet fuel prices, with United down more than 2.5% and Southwest and Delta both declining 2%.

🤖 Palantir stock rebounded more than 2% after a recent sharp sell-off related to AI disruption fears for software business models.

🛏️ Leggett & Platt jumped 9% on an agreement to be acquired by Somnigroup International in an anticipated $2.5 billion all-stock deal closing year-end 2026.

Bullish Signals
  • Goldman Sachs reported an earnings per share of $17.55 and revenue of $17.23 billion, both exceeding consensus estimates of $16.49 and $16.97 billion respectively.
  • Revolution Medicines stock surged more than 37% after its pancreatic cancer drug daraxonrasib led patients to live 13.2 months compared to 6.7 months for chemotherapy users.
  • Williams-Sonoma gained more than 2% following a Goldman Sachs upgrade to buy, with analysts noting the company has one of the strongest portfolios of brands in retail.
  • Toll Brothers and Pultegroup shares rose more than 1% after Evercore ISI upgraded both homebuilders to outperform, citing that bad news is already priced in.
  • Leggett & Platt manufacturer jumped 9% after announcing an agreement to be acquired by Somnigroup International for $2.5 billion in stock, with the deal expected to close by year-end 2026.
  • Palantir shares rebounded by more than 2% after a sharp sell-off, demonstrating resilience amid concerns that artificial intelligence will disrupt software companies' business models.
Risk Factors
  • Goldman Sachs shares fell more than 2% in premarket trading despite reporting earnings and revenue beats.
  • Goldman's fixed income, currencies and commodities unit generated $4.01 billion in trading, which was well short of the $4.92 billion consensus estimate.
  • Goldman Sachs downgraded Best Buy to sell, causing shares to drop 4%, citing risks to sales post-Q1 from higher memory costs affecting laptop and computer prices.
  • Cruise line stocks faced downward pressure due to higher input costs from rising energy prices and fears over demand, with Carnival falling 4% and Royal Caribbean slipping more than 2%.
  • Airline names declined on Monday amid similar demand fears and higher jet fuel prices, with United Airlines falling by more than 2.5% and Southwest Airlines and Delta Air Lines both declining 2%.
  • Palantir shares rebounded only after a sharp 13.4% sell-off last week driven by concerns that artificial intelligence will disrupt software companies' business models.
  • Targa Resources, APA Corporation, Phillips 66, Chevron, and Exxon Mobil are all energy names rose due to oil prices climbing above $103 following the U.S. navy blockade on the Strait of Hormuz, indicating heightened geopolitical volatility in energy markets.
  • Fastenal's stock slid more than 4% after reporting first-quarter earnings that merely met the Street's expectations, rather than exceeding them.
Full Analysis
Goldman Sachs shares fell more than 2% in premarket trading on Monday despite reporting a first-quarter earnings and revenue beat, with earnings per share of $17.55 and revenue of $17.23 billion, both exceeding consensus estimates. However, the bank's fixed income, currencies, and commodities unit saw trading volume of $4.01 billion, missing the $4.92 billion analyst consensus. Elsewhere, Goldman Sachs upgraded Williams-Sonoma to a buy rating due to attractive valuation levels and strong brand portfolio, sending shares up more than 2%, while downgrading Best Buy to sell on concerns about future sales risks following higher memory costs in PCs, causing its stock to drop 4%. In the biotech sector, Revolution Medicines saw its stock surge over 37% after announcing that its pancreatic cancer drug, daraxonrasib, succeeded in a phase 3 trial, showing patients lived 13.2 months compared to 6.7 months on chemotherapy. The homebuilding and construction space received upgrades from Evercore ISI for Toll Brothers and Pultegroup, pushing shares higher than 1% as the firm suggested macroeconomic headwinds are manageable for these names. Fastenal slid more than 4% despite reporting first-quarter earnings that met Street expectations at 30 cents per share and $2.2 billion in revenue. Sector-wide movements were heavily influenced by energy markets, where oil prices climbed above $103 following a U.S. navy blockade announcement on the Strait of Hormuz, lifting stocks like Targa Resources and Chevron. Conversely, cruise line and airline shares declined due to fears over demand and higher input costs, with Carnival down 4% and United Airlines falling more than 2.5%. Palantir shares rebounded over 2% after a sharp sell-off last week related to AI disruption concerns, while Leggett & Platt jumped 9% on news of an agreed acquisition by Somnigroup International for $2.5 billion in stock, expected to close by year-end 2026.